Nuveen’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Hold
210,379
﹤0.01% 2966
2025
Q4
$299K Buy
210,379
+76,629
+57% +$112K ﹤0.01% 3046
2025
Q3
$219K Buy
133,750
+38,694
+41% +$43K ﹤0.01% 3136
2025
Q2
$69.5K Hold
95,056
﹤0.01% 3262
2025
Q1
$76.7K Hold
95,056
﹤0.01% 3238
2024
Q4
$131K Hold
95,056
﹤0.01% 3269
2024
Q3
$98.9K Hold
95,056
﹤0.01% 3310
2024
Q2
$164K Hold
95,056
﹤0.01% 3252
2024
Q1
$227K Sell
95,056
-666,263
-88% -$1.64M ﹤0.01% 3159
2023
Q4
$2.54M Sell
761,319
-219,406
-22% -$588K ﹤0.01% 2302
2023
Q3
$3.67M Buy
980,725
+700,899
+250% +$3.24M ﹤0.01% 2020
2023
Q2
$1.19M Buy
279,826
+104,167
+59% +$615K ﹤0.01% 2584
2023
Q1
$1.2M Sell
175,659
-286,867
-62% -$2.23M ﹤0.01% 2543
2022
Q4
$3.66M Sell
462,526
-266,911
-37% -$2.05M ﹤0.01% 2090
2022
Q3
$7.01M Sell
729,437
-158,148
-18% -$1.6M ﹤0.01% 1697
2022
Q2
$6.43M Sell
887,585
-142,021
-14% -$1.23M ﹤0.01% 1783
2022
Q1
$12.5M Buy
1,029,606
+323,408
+46% +$4.11M ﹤0.01% 1501
2021
Q4
$11.3M Sell
706,198
-17,745
-2% -$310K ﹤0.01% 1617
2021
Q3
$11.6M Sell
723,943
-36,788
-5% -$539K ﹤0.01% 1674
2021
Q2
$10.5M Buy
760,731
+83,940
+12% +$1.19M ﹤0.01% 1835
2021
Q1
$9.89M Buy
676,791
+15,985
+2% +$271K ﹤0.01% 1808
2020
Q4
$11.5M Sell
660,806
-479,065
-42% -$8.53M ﹤0.01% 1619
2020
Q3
$20.9M Sell
1,139,871
-3,004
-0.3% -$55.9K 0.01% 1032
2020
Q2
$20.4M Sell
1,142,875
-100,961
-8% -$1.71M 0.01% 1036
2020
Q1
$20.2M Sell
1,243,836
-697,864
-36% -$12.9M 0.01% 897
2019
Q4
$35M Buy
1,941,700
+111,785
+6% +$2.06M 0.01% 862
2019
Q3
$37.1M Buy
1,829,915
+667,224
+57% +$13.3M 0.02% 811
2019
Q2
$25.7M Buy
+1,162,691
New +$20.2M 0.01% 1024

Other funds holding CHRS